1. Chen, Shimei, Zhang, Jian, Sun, Dandan, Wei, Fang, Sun, Qiao. . SYVN1 Promotes STAT3 Protein Ubiquitination and Exerts Antiangiogenesis Effects in Retinopathy of Prematurity Development. In Investigative ophthalmology & visual science, 64, 8. doi:10.1167/iovs.64.11.8. https://pubmed.ncbi.nlm.nih.gov/37540175/
2. Peng, Peng, Ren, Yuliang, Wan, Fang, Si, Yuan, Liu, Ying. 2023. Sculponeatin A promotes the ETS1-SYVN1 interaction to induce SLC7A11/xCT-dependent ferroptosis in breast cancer. In Phytomedicine : international journal of phytotherapy and phytopharmacology, 117, 154921. doi:10.1016/j.phymed.2023.154921. https://pubmed.ncbi.nlm.nih.gov/37327642/
3. Yang, Shuo, He, Heng, Ma, Qi Si, Liu, Lei, Li, Bin. 2015. Experimental study of the protective effects of SYVN1 against diabetic retinopathy. In Scientific reports, 5, 14036. doi:10.1038/srep14036. https://pubmed.ncbi.nlm.nih.gov/26358086/
4. Vermeulen, Christie, Brachtlova, Tereza, Tol, Nikki, van de Vrugt, Henri J, van Beusechem, Victor W. 2022. Evaluation of a Novel Oncolytic Adenovirus Silencing SYVN1. In International journal of molecular sciences, 23, . doi:10.3390/ijms232315430. https://pubmed.ncbi.nlm.nih.gov/36499754/
5. Xie, Wei, Shi, Lei, Quan, Hu, Chen, Pan, Li, Zhiyuan. 2023. SYVN1 ubiquitinates FoxO1 to induce β-catenin nuclear translocation, PD-L1-mediated metastasis, and immune evasion of hepatocellular carcinoma. In Cellular oncology (Dordrecht, Netherlands), 46, 1285-1299. doi:10.1007/s13402-023-00811-y. https://pubmed.ncbi.nlm.nih.gov/37099251/